We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Scott Bass Sidley Austin LLP

Results 1 to 5 of 72



China develops new rules to simplify medical device re-registration process *

China - April 1 2013
China's newly restructured food and drug regulatory agency, the China Food and Drug Administration ("CFDA"), has published new draft rules to…

Co-authors: Paul E. Kalb, M.D, James C. Stansel, David J. Zampa, M. Patricia Thayer, Michael W. Davis.


SFDA 2012 Anual Drug Review Report highlights innovator focus *

China - March 8 2013
On February 28, 2013, the Center for Drug Evaluation of the State Foodand Drug Administration ("CDE"), the key agency reviewing safety andefficacy…

Co-authors: James C. Stansel.


FDA finalizes guidance to address potential bias and conflicts of interest in clinical investigations *

USA - March 1 2013
FDA has finalized its guidance on financial disclosure for clinical investigators. A draft of the guidance, published in May 2011, was developed in…

Co-authors: James C. Stansel, Raymond A. Bonner, Coleen Klasmeier.


Top 10 steps global life sciences companies should take in 2013 *

USA - March 1 2013
Engage in US budget and deficit reduction process. As governments, including the US and China, search for the means to fund priorities or reduce…

Co-authors: Paul E. Kalb, M.D, James C. Stansel, David J. Zampa, M. Patricia Thayer, Michael W. Davis.


China amends major regulation on drug distribution *

China - February 25 2013
On January 22, 2013, the Ministry of Health of China published the amended Good Supply Practice for Drugs ("Drug GSP"). Drug GSP is one of the key…

Co-authors: James C. Stansel.


Next »